Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Lifestyle Diseases
4.2.2 Technological Advancements in Metabolic Testing
4.3 Market Restraints
4.3.1 High Cost of Equipment and Software
4.3.2 Poor Reimbursement Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Equipment Type
5.1.1 Body Composition Analyzers
5.1.2 Cardiopulmonary Exercise Testing (CPET) Systems
5.1.3 ECG Systems
5.1.4 Metabolic Carts
5.1.5 Others
5.2 By Application
5.2.1 Critical Care
5.2.2 Lifestyle Diseases
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Sports Training Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 MGC Diagnostics Corporation
6.1.2 COSMED srl
6.1.3 CORTEX Biophysik GmbH
6.1.4 GE Healthcare (General Electric Company)
6.1.5 KORR Medical Technologies, Inc
6.1.6 CareFusion Corporation
6.1.7 Geratherm Medical AG
6.1.8 OSI Systems, Inc
6.1.9 AEI Technologies, Inc
6.1.10 Parvo Medics


7 MARKET OPPORTUNITIES AND FUTURE TRENDS